The trial will run for a period of five years. The researchers will evaluate how the drugs affect blood sugar levels, diabetes complications and quality of life, as well as the medications’ side effects.
“In addition to determining which medications control sugar most effectively over time, we will examine individual factors associated with better or worse response to different drugs,” said Janet B. McGill, MD, professor of medicine and principal investigator at the Washington University study site. “This is a long-term study that will provide targeted diabetes care at no cost to participants.”
“For more information or to volunteer, call study coordinator Lori Buechler at 314-362-8285, e-mail GRADESTUDY@wustl.edu or visit the study’s website,” http://endo.wustl.edu/current-clinical-studies/.